Genesis Healthcare (NYSE:GEN) Releases Quarterly Earnings Results, Beats Expectations By $0.49 EPS

Genesis Healthcare (NYSE:GEN) posted its quarterly earnings results on Thursday. The company reported $0.40 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.49, Fidelity Earnings reports. The business had revenue of $1.12 billion during the quarter, compared to the consensus estimate of $1.13 billion.

Shares of NYSE:GEN traded up $0.04 during trading hours on Friday, hitting $1.54. The company’s stock had a trading volume of 250,507 shares, compared to its average volume of 214,777. Genesis Healthcare has a 52 week low of $0.92 and a 52 week high of $1.74. The company has a market capitalization of $230.69 million, a price-to-earnings ratio of -0.99 and a beta of 0.93. The firm’s fifty day moving average price is $1.31 and its 200 day moving average price is $1.23.

About Genesis Healthcare

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Article: What causes a stock to be most active?

Earnings History for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply